CONTENTS:
- Substances from unregulated drug markets - A retrospective data analysis of customer-provided samples from a decade of drug checking service in Zurich (Switzerland). Magnolini R., Schneider M., Schori D., Trachsel D., Bruggmann P., art. 103972.
- Liminal spaces, seasonal faces: Challenging drug market assumptions via an exploration of naturally occurring magic mushroom markets in rural Kent. Simpson G.H.R., Chatwin C., van Hellemont E., art. 103973.
- The effects of the 4/20 cannabis holiday and adult-use cannabis legalization on medical cannabis sales and medical cannabis patient registration in Arizona. Meier M.H., Meier M.A., Anderson S.F., Schaffer A.L., Waddell J.T., Roman B.A., et al., art. 103974.
- Decline in youth drinking in high-income settings: Implications for public health in low-income countries. Dumbili E.W., art. 103975.
- Age-specific disparities in fatal drug overdoses highest among older black adults and American Indian/Alaska native individuals of all ages in the United States, 2015-2020. Jones A., Santos-Lozada A., Perez-Brumer A., Latkin C., Shoptaw S., El-Bassel N., art. 103977.
- Health and correctional staff acceptability of depot buprenorphine in NSW prisons. Little S., White B., Moensted M., Butler K., Howard M., Roberts J., et al., art. 103978.
- The Liver King Lie: Misrepresentation, justification, and public health implications. Gibbs N., Piatkowski T., art. 103979.
- Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states. Bruzelius E., Cerda M., Davis C.S., Jent V., Wheeler-Martin K., Mauro C.M., et al., art. 103980.
- The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination. Young J., Wang S., Lanièce Delaunay C., Cooper C.L., Cox J., Gill M.J., et al., art. 103981.
- Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study. Grebely J., Gilliver R., McNaughton T., Conway A., Cunningham E., Henderson C., et al., art. 103982.
- Clearing cannabis criminal records: A survey of criminal record expungement availability and accessibility among US States and Washington DC that decriminalized or legalized cannabis. Wakefield T., Bialous S., Apollonio D.E., art. 103983.
- Changes in hazardous drinking pre, during and post 70-day alcohol sales ban during COVID-19 pandemic in Botswana. Maphisa Maphisa J., Ndlovu T.B.H., art. 103992.
- The opioid industry document archive: New directions in research on corporate political strategy. MacKenzie R., Hawkins B., Klein D.E., Ahmad M., Norman A.K., Koon A.D., art. 103997.
- "You'll come in and dose even in a global pandemic": A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic. Conway A., Treloar C., Crawford S., Degenhardt L., Dore G.J., Farrell M., et al., art. 103998.
- "I am not a junkie": Social categorization and differentiation among people who use drugs. Sibley A.L., Baker R., Levander X.A., Rains A., Walters S.M., Nolte K., et al., art. 103999.